|
JPH10130258A
(ja)
*
|
1996-10-10 |
1998-05-19 |
Eli Lilly & Co |
ベンゾ［ｂ］チオフェン化合物、中間体、製剤、および方法
|
|
ES2232946T3
(es)
|
1997-04-30 |
2005-06-01 |
Eli Lilly And Company |
Agentes antitromboticos.
|
|
US6172100B1
(en)
|
1997-04-30 |
2001-01-09 |
Eli Lilly And Company |
Antithrombotic agents
|
|
JP2002513415A
(ja)
|
1997-04-30 |
2002-05-08 |
イーライ・リリー・アンド・カンパニー |
抗血栓剤
|
|
WO1998048794A1
(en)
*
|
1997-04-30 |
1998-11-05 |
Eli Lilly And Company |
Antithrombotic agents
|
|
ATE268768T1
(de)
*
|
1997-04-30 |
2004-06-15 |
Lilly Co Eli |
Antithrombosemittel
|
|
EP1019047B1
(en)
|
1997-05-01 |
2003-11-05 |
Eli Lilly And Company |
Antithrombotic agents
|
|
US7008950B1
(en)
|
1997-06-05 |
2006-03-07 |
Takeda Chemical Industries, Ltd. |
Benzofurans as suppressors of neurodegeneration
|
|
US6017914A
(en)
*
|
1997-09-03 |
2000-01-25 |
Eli Lilly And Company |
Benzo[b]thiophene compounds, intermediates, formulations, and methods
|
|
US6284756B1
(en)
|
1998-04-30 |
2001-09-04 |
Eli Lilly And Company |
Antithrombotic agents
|
|
US6166069A
(en)
*
|
1998-05-12 |
2000-12-26 |
American Home Products Corporation |
Phenyl oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia
|
|
ATE229520T1
(de)
*
|
1998-10-28 |
2002-12-15 |
Lilly Co Eli |
Benzothiophenderivate als antithrombotische mitteln und zwischenprodukte
|
|
ES2213984T3
(es)
|
1998-10-30 |
2004-09-01 |
Eli Lilly And Company |
Derivados de azaindol y su uso como agentes antitrombicos.
|
|
US6620837B1
(en)
*
|
1999-11-19 |
2003-09-16 |
Eli Lilly And Company |
Antithrombotic agents
|
|
DK1401446T3
(da)
|
2001-05-22 |
2005-05-23 |
Lilly Co Eli |
Tetrahydroquinolinderivater til inhiberingen af sygdomme forbundet med estrogenmangel eller med en urelgelmæssig fysiologisk reaktion til endogent estrogen
|
|
ATE321754T1
(de)
|
2001-05-22 |
2006-04-15 |
Lilly Co Eli |
2-substituierte 1,2,3,4-tetrahydrochinoline und derivate davon, zusammensetzungen und verfahren
|
|
JP5082033B2
(ja)
|
2001-12-21 |
2012-11-28 |
エグゼリクシス パテント カンパニー エルエルシー |
Ｌｘｒのモジュレーター
|
|
US7482366B2
(en)
|
2001-12-21 |
2009-01-27 |
X-Ceptor Therapeutics, Inc. |
Modulators of LXR
|
|
AU2003253129B2
(en)
*
|
2002-07-22 |
2008-12-11 |
Eli Lilly And Company |
Selective estrogen receptor modulators containing a phenylsulfonyl group
|
|
US7296361B2
(en)
*
|
2003-07-31 |
2007-11-20 |
University Of Pittsburgh |
Measuring device and method of measuring
|
|
LT2896397T
(lt)
|
2003-08-01 |
2017-11-27 |
Mitsubishi Tanabe Pharma Corporation |
Nauji junginiai, turintys inhibitorinį aktyvumą prieš nuo natrio priklausomą gliukozės transporterį
|
|
US8785403B2
(en)
|
2003-08-01 |
2014-07-22 |
Mitsubishi Tanabe Pharma Corporation |
Glucopyranoside compound
|
|
WO2006084338A1
(en)
|
2005-02-14 |
2006-08-17 |
Bionomics Limited |
Novel tubulin polymerisation inhibitors
|
|
GB0507577D0
(en)
|
2005-04-14 |
2005-05-18 |
Novartis Ag |
Organic compounds
|
|
UY30730A1
(es)
|
2006-12-04 |
2008-07-03 |
Mitsubishi Tanabe Pharma Corp |
Forma cristalina del hemihidrato de 1-(b (beta)-d-glucopiranosil) -4-metil-3-[5-(4-fluorofenil) -2-tienilmetil]benceno
|
|
MY162628A
(en)
|
2007-09-10 |
2017-06-30 |
Janssen Pharmaceutica Nv |
Process for the preparation of compounds useful as inhibitors of sglt
|
|
CL2008003653A1
(es)
|
2008-01-17 |
2010-03-05 |
Mitsubishi Tanabe Pharma Corp |
Uso de un inhibidor de sglt derivado de glucopiranosilo y un inhibidor de dppiv seleccionado para tratar la diabetes; y composicion farmaceutica.
|
|
US9056850B2
(en)
|
2008-10-17 |
2015-06-16 |
Janssen Pharmaceutica N.V. |
Process for the preparation of compounds useful as inhibitors of SGLT
|
|
US20110009347A1
(en)
|
2009-07-08 |
2011-01-13 |
Yin Liang |
Combination therapy for the treatment of diabetes
|
|
PT2488515T
(pt)
|
2009-10-14 |
2017-04-11 |
Janssen Pharmaceutica Nv |
Processo para a preparação de compostos úteis como inibidores de sglt2
|
|
KR101931209B1
(ko)
|
2010-05-11 |
2018-12-20 |
얀센 파마슈티카 엔.브이. |
Sglt의 억제제로서 1-(베타-d-글루코피라노실)-2-티에닐-메틸벤젠 유도체를 포함하는 약학 제형
|
|
ME02469B
(me)
|
2011-04-13 |
2017-02-20 |
Janssen Pharmaceutica Nv |
Proces za pripremu jedinjenja koja su korisna kao inhibitori sglt2
|
|
TWI542596B
(zh)
|
2011-05-09 |
2016-07-21 |
健生藥品公司 |
（２ｓ,３ｒ,４ｒ,５ｓ,６ｒ）－２－（３－（（５－（４－氟苯基）噻吩－２－基）甲基）－４－甲基苯基）－６－（羥甲基）四氫－２ｈ－哌喃－３,４,５－三醇之ｌ－脯胺酸及檸檬酸共晶體
|
|
CA2862981C
(en)
|
2011-12-15 |
2020-02-25 |
Bayer Pharma Aktiengesellschaft |
Substituted benzothienyl-pyrrolotriazines and uses thereof in the treatment cancer
|
|
US9475815B2
(en)
|
2012-02-23 |
2016-10-25 |
Bayer Intelletual Property Gmbh |
Substituted benzothienyl-pyrrolotriazines and uses thereof
|
|
KR20170118687A
(ko)
*
|
2015-02-19 |
2017-10-25 |
제이엔씨 주식회사 |
벤조티오펜을 가지는 액정성 화합물, 액정 조성물 및 액정 표시 소자
|
|
US20170071970A1
(en)
|
2015-09-15 |
2017-03-16 |
Janssen Pharmaceutica Nv |
Co-therapy comprising canagliflozin and phentermine for the treatment of obesity and obesity related disorders
|
|
CN109311848B
(zh)
|
2016-06-07 |
2022-02-01 |
北京加科思新药研发有限公司 |
可用作shp2抑制剂的新型杂环衍生物
|
|
US10988466B2
(en)
|
2017-03-23 |
2021-04-27 |
Jacobio Pharmaceuticals Co., Ltd. |
Heterocyclic derivatives useful as SHP2 inhibitors
|
